As shown in Figure 1 and Supplementary Figure S4, compared to that of control and blank group, serum TG, TCHO, and LDL levels, as well as hepatic AST, ALT, TG, and TCHO levels of the model group were significantly increased, whereas serum HDL levels were significantly decreased, indicating that the hyperlipidemia and hepatic steatosis were developed in the model group. The gene discussed is GPT; the disease is fatty liver disease.